#Proteomic profiling of #SmallCellLungCancer reveals PS1 and PS2 subtypes with distinct #neuroendocrine, metabolic, and immune features, showing prognostic differences and highlighting PS2’s immune cluster as vulnerable to #immunotherapy.
#OpenAccess: doi.org/10.1016/j.ge...